MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination

M.J. Sollman, J.G. Hesse, B.C. Sachs, J.F. Cook (Winston-Salem, NC, USA)

Meeting: 2016 International Congress

Abstract Number: 1451

Keywords: Cognitive dysfunction, Deep brain stimulation (DBS), Dementia

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Cognition

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate utility of the DRS-II Total Score for stratifying cognitive status in PD patients without frank cognitive impairment.

Background: The DRS-II, a screening tool for dementia, is commonly used to stratify DBS-related cognitive risk. Some institutions employ a cut score, whereby individuals failing to meet this are not offered DBS. However, the utility of this practice has not been empirically supported. Evaluation of raw scores suggests that one subscale (I/P), which gives great weight to a measure of semantic verbal fluency, may contribute differentially to Total Score. Unfortunately, PD patients’ performance on I/P is heavily influenced by medication on/off state and medication response. We sought to evaluate contributors to DRS-II Total Score to evaluate potential for bias, and to identify alternate predictors of overall cognitive status in our presurgical PD group.

Methods: We conducted an archival analysis of medication-on DRS-II performance in PD patients undergoing presurgical workup. Individuals with frank impairment (i.e., <5th percentile) were excluded. After standardizing raw scores, regression analysis and correlation matrices were utilized to illustrate contribution of subscale performances to Total Score. Alternative predictors of overall cognitive health were then identified.

Results: 228 pre-surgical PD-DBS patients met inclusion criteria of DRS-II Total >120 (i.e., not Impaired). Mean age was 64.7 (8.4) years, mean education was 14.1 (2.8) years, and mean disease duration was 9.7 (5.3) years. All DRS subscales correlated significantly with Total score (< .05), but I/P scores were more highly correlated than any other subscale (r = .803). Within I/P, 94% of variance was accounted for by fluency. Sequential multiple regression model supported I/P as optimal predictor (p < .001), explaining 65% of variance in Total Score. Addition of Con and Att contributed significantly (p <.01). Fluency from I/P correlated equivalently with both another semantic task (Animal Naming, r= .588) and letter fluency (FAS, r = .506).

Conclusions: DRS-II Total Score was disproportionately impacted by medication-on I/P performance, which relies heavily on semantic fluency. Verbal fluency is additionally known to be susceptible to medication off states, which may result in further underestimate of capability. Use of DRS-II Total cut scores is not supported.

To cite this abstract in AMA style:

M.J. Sollman, J.G. Hesse, B.C. Sachs, J.F. Cook. Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/use-of-dementia-rating-scale-ii-drs-ii-total-score-in-pd-deep-brain-stimulation-dbs-candidacy-determination/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/use-of-dementia-rating-scale-ii-drs-ii-total-score-in-pd-deep-brain-stimulation-dbs-candidacy-determination/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley